Daniel Schultz - UPI.com

Topic: Daniel Schultz

Daniel Schultz is the subject or is mentioned in the following stories:

FDA approves temporary heart pump

WASHINGTON, Oct. 7 (UPI) -- The U.S. Food and Drug Administration said it has granted an exemption for the first heart pump that provides temporary support for the heart's right side.

FDA approves hepatitis B viral DNA test

WASHINGTON, Sept. 4 (UPI) -- The U.S. Food and Drug Administration has approved the first hepatitis B nucleic acid test that measures the amount of viral DNA in a patient's blood.

FDA OKs Medtronic defibrillator upgrade

WASHINGTON, Sept. 4 (UPI) -- The U.S. Food and Drug Administration approved a software update to detect problems in some of Medtronic Inc.'s Sprint Fidelis defibrillators.

FDA OKs post surgery transplant test

WASHINGTON, Aug. 27 (UPI) -- The U.S. Food and Drug Administration has approved a non-invasive molecular test to aid doctors in managing heart transplant patients after surgery.

FDA approves tumor identification test

WASHINGTON, July 31 (UPI) -- The U.S. Food and Drug Administration has approved a test that can identify cancer cells contained within a malignant tumor.

FDA approves diaphragm-pacing device

WASHINGTON, June 18 (UPI) -- The U.S. Food and Drug Administration has approved a device that stimulates the diaphragm and allows some people to breathe without a mechanical ventilator.

FDA OK's arterial plaque imaging device

WASHINGTON, April 29 (UPI) -- The U.S. Food and Drug Administration said it has approved a device that can see inside a blood vessel to assess the fat content of the arterial plaque.

FDA approves new respiratory virus test

WASHINGTON, Jan. 21 (UPI) -- The U.S. Food and Drug Administration has approved a test that detects four respiratory viruses, including the flu, in a patient's respiratory secretions.

New genetic breast cancer test is approved

WASHINGTON, Jan. 15 (UPI) -- The U.S. Food and Drug Administration has approved a test that helps assess the risk of tumor recurrence in high-risk breast cancer patients.

Company warns of heart device malfunctions

MINNEAPOLIS , Oct. 15 (UPI) -- Implanted heart device manufacturer Medtronic of Minneapolis is asking doctors to discontinue use of a component in its newest defibrillator models.